ISSN: 1477-9072

Journal Home

Journal Guideline

Expert Review of Cardiovascular Therapy Q2 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Expert Review of Cardiovascular Therapy is a journal indexed in SJR in Medicine (miscellaneous) and Internal Medicine with an H index of 61. It has a price of 4000 €. It has an SJR impact factor of 0,635 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,635.

Expert Review of Cardiovascular Therapy focuses its scope in these topics and keywords: cardiovascular, factor, aging, risk, von, willebrand, whatadvances, venous, disease, management, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cardiology and Cardiovascular Medicine (Q2) Internal Medicine (Q2) Medicine (miscellaneous) (Q2)

Price

4000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,635

SJR Impact factor

61

H Index

94

Total Docs (Last Year)

287

Total Docs (3 years)

7290

Total Refs

533

Total Cites (3 years)

259

Citable Docs (3 years)

1.73

Cites/Doc (2 years)

77.55

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

Acute aortic syndromes: aortic dissections, penetrating aortic ulcers and intramural aortic hematomas

Combined hypertension and orthostatic hypotension in older patients: a treatment dilemma for clinicians

Gender differences in the clinical features and outcomes of patients with coronary artery disease

The role of cardiovascular magnetic resonance in the evaluation of patients with heart failure

Fixed combination therapy of hypertension: focus on valsartan/hydrochlorothiazide combination (Diovan¬Æ/HCT)

Brugada syndrome: clinical, genetic, molecular, cellular and ionic aspects

The evolution and revolution of the implantable cardioverter defibrillator

Dofetilide: a new class III antiarrhythmic agent

Renal participation in cardiovascular risk inessential hypertension

Stroke in pregnant and postpartum women

Statin myopathy as a metabolic muscle disease

N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure

SHOW MORE ARTICLES

Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery

How to improve endothelial repair mechanisms: the lifestyle approach

Transesophageal echocardiography: a complementary view of the heart

A comparison of alternative access routes for transcatheter aortic valve implantation

Cardiovascular effects of selective cyclooxygenase-2 inhibitors

Bicuspid aortic valve disease: recent insights in pathophysiology and treatment

Percutaneous aortic valve replacement: more than palliation?

Ambulatory blood pressure monitoring and prognosis in the management of essential hypertension

Etiology of valvular heart disease

Vascular protectants for the treatment of atherosclerosis

Tirofiban in acute coronary syndromes

Endo-exuberance and abdominal aortic aneurysm management: have we gone too far?